Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL

Enrollment

76,130

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone/salmeterol combination (FSC) 250/50mcg

patients initiating treatment with fluticasone/salmeterol combination (FSC) 250/50mcg

DRUG

tiotropium

patients initiating treatment with tiotropium

DRUG

ipratropium bromide alone or in fixed dose combination with albuterol

patients initiating treatment with ipratropium/albuterol